Exclusive

Publication

Byline

Location

International Clinical Trial: Parental Mindfulness as a Moderated Mediator in the Relationship Between Authoritarian Parenting and Anxiety in Children with Tic Disorders

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127244) titled 'Parental Mindfulness as a Moderated Mediator in the Relationship Between A... Read More


International Clinical Trial: The Improvement Effects and Mechanisms of Hemp Peptide in Patients with Non-Alcoholic Fatty Liver Disease

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127239) titled 'The Improvement Effects and Mechanisms of Hemp Peptide in Patients with No... Read More


International Clinical Trial: A Comparative Study of Robotic Bronchoscopy and Percutaneous Ablation for Pulmonary Nodules

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127243) titled 'A Comparative Study of Robotic Bronchoscopy and Percutaneous Ablation for ... Read More


Clinical Trial: Study of Daily Life Activities and Psychological Status After Deep Brain Stimulation in Parkinson's Disease (Japan)

Tokyo, June 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062080) titled 'Study of Daily Life Activities and Psychological Status After Deep Brain St... Read More


Clinical Trial: Effects of Acupuncture Stimulation at Active Trigger Points and Non-Trigger Point Sites on Quantitative Sensory Testing in Patients with Chronic Low Back Pain: A Randomized Controlled Trial (Japan)

Tokyo, June 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062066) titled 'Comparison of the Effects of Different Acupuncture Sites on Pain in People ... Read More


Clinical Trial: Investigation of Catheter Displacement and Bleeding at the Skin Insertion Site of Epidural Catheters (Japan)

Tokyo, June 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062063) titled 'Assessment of catheter displacement at the insertion site and bleeding stat... Read More


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, June 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 26 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 26 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 26 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More